Soluble Guanylate Cyclase Activators and Stimulators in Patients with Heart Failure

被引：0
作者：
Wei-Lin Liang
Bo Liang
机构：
[1] Guangyuan Hospital of Chinese Medicine,Department of Cardiology
[2] Xinqiao Hospital,Department of Nephrology, The Key Laboratory for the Prevention and Treatment of Chronic Kidney Disease of Chongqing, Chongqing Clinical Research Center of Kidney and Urology Diseases
[3] Army Medical University (Third Military Medical University),undefined
来源：
Current Cardiology Reports | 2023年 / 25卷
关键词：
Heart failure; Cardiac pharmacology; Soluble guanylate cyclase activators and stimulators; Cinaciguat; Riociguat; Vericiguat; Praliciguat;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：607 / 613
页数：6
相关论文
共 50 条
  • [31] Soluble Guanylate Cyclase Activation With Cinaciguat A New Approach to the Treatment of Decompensated Heart Failure
    Hingorany, Shipra
    Frishman, William H.
    CARDIOLOGY IN REVIEW, 2011, 19 (01) : 23 - 29
  • [32] The Role of sGC Stimulators and Activators in Heart Failure With Reduced Ejection Fraction
    Cordwin, David J.
    Berei, Theodore J.
    Pogue, Kristen T.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2021, 26 (06) : 593 - 600
  • [33] Soluble Guanylate Cyclase Stimulators for Chronic Thromboembolic Pulmonary Hypertension Patients Treatment: New Data
    Simakova, Maria A.
    Moiseeva, Olga M.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2020, 16 (02) : 317 - 323
  • [34] Vericiguat: The First Soluble Guanylate Cyclase Stimulator for Reduction of Cardiovascular Death and Heart Failure Hospitalization in Patients With Heart Failure Reduced Ejection Fraction
    Tran, Bao-Anh
    Serag-Bolos, Erini S.
    Fernandez, Joel
    Miranda, Aimon C.
    JOURNAL OF PHARMACY PRACTICE, 2023, 36 (04) : 905 - 914
  • [35] Soluble guanylyl cyclase stimulators and activators: Promising drugs for the treatment of hypertension?
    Gawrys, Olga
    Kala, Petr
    Sadowski, Janusz
    Melenovsky, Vojtech
    Sandner, Peter
    Cervenka, Ludek
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2025, 987
  • [36] Bibliometric study of soluble guanylate cyclase stimulators in cardiovascular research based on web of science from 1992 to 2021
    Jia, Xiao-Yan
    Liu, Yong-Ming
    Wang, Yong-Fei
    An, Jin-Yang
    Peng, Ke-Ling
    Wang, Hua
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [37] Guanylate cyclase stimulators for pulmonary hypertension
    Wardle, Andrew J.
    Seager, Matthew J.
    Wardle, Richard
    Tulloh, Robert M. R.
    Gibbs, J. Simon R.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (08):
  • [38] Targeting heme-oxidized soluble guanylate cyclase in experimental heart failure
    Boerrigter, Guido
    Costello-Boerrigter, Lisa C.
    Cataliotti, Alessandro
    Lapp, Harald
    Stasch, Johannes-Peter
    Burnett, John C., Jr.
    HYPERTENSION, 2007, 49 (05) : 1128 - 1133
  • [39] Soluble guanylate cyclase stimulators for the treatment of hypertension: Discovery of MK-2947
    Brockunier, Linda
    Stelmach, John
    Guo, Jian
    Spencer, Tracy
    Rosauer, Keith
    Bansal, Alka
    Cai, Sheng-Jian
    Chen, Nancy
    Cummings, John
    Huang, Li
    Johnson, Timothy
    Levesque, Sonia
    Luo, Lin
    Maloney, Kevin
    Metzger, Joseph
    Mortko, Christopher
    Ortega, Karen
    Pai, Lee-Yuh
    Pereira, Antonio
    Salituro, Gino
    Shang, Jackie
    Shepherd, Cherrie
    Xu, Shiyao Sherrie
    Yang, Qifeng
    Cui, Jisong
    Roy, Sophie
    Parmee, Emma
    Raghavan, Subharekha
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (21)
  • [40] Cinaciguat, a soluble guanylate cyclase activator, unloads the heart but also causes hypotension in acute decompensated heart failure
    Erdmann, Erland
    Semigran, Marc J.
    Nieminen, Markku S.
    Gheorghiade, Mihai
    Agrawal, Rahul
    Mitrovic, Veselin
    Mebazaa, Alexandre
    EUROPEAN HEART JOURNAL, 2013, 34 (01) : 57 - 67
12345